Spyre Therapeutics, Inc. (SYRE): 8-K filed Aug 25, 2026

Form type

8-K

Filing date

Aug 25, 2026

Accession number

0001636282-26-000105

Filer

Spyre Therapeutics, Inc. (CIK 1636282)